Navigating Complexities of Name Changes and Re Registrations
Medical device manufacturers often overlook the complexities involved in changing product names or ownership, both of which...
Browse Content
Merger and Acquisition Re Registration: Navigating the Re Registration and other Complexities of M and A and Carve Outs
In M&A or carve-outs, pharmaceutical executives often underestimate the complexities of disentangling operations and the extensive effort...
Pharma Product Launch and Lessons Leaned Crisis Playbook: Lessons learned from Real Investigations of Product Failures
When a medical or pharmaceutical product fails in the field, the repercussions are far-reaching. Not only do...
Life Science Due Diligence Beyond the Obvious: Managing Business Risks During Life Science M and A Due Diligence
In the business press, discussions of mergers or acquisitions (M&A) invariably highlight the high percentages of deals...
The Metrics of Quality Culture
The long-awaited and anxiously anticipated FDA guidance on quality metrics was finally distributed for comment on July...